COMMUNIQUÉS West-GlobeNewswire

MacroGenics Announces Poster Presentation on Preclinical PD-L1 x CD137 DART® Program at the EORTC-NCI-AACR Symposium in Dublin
14/11/2018
ROCKVILLE, MD, Nov. 14, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]
CURE Pharmaceutical Names Veteran Executive as Chief Financial Officer
14/11/2018
OXNARD, Calif., Nov. 14, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced it has tapped Alex Katz to be the company’s Chief Financial Officer [...]
Iterum Reports Third Quarter 2018 Financial Results and Recent Highlights
14/11/2018
DUBLIN, Ireland and CHICAGO, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM), a clinical-stage pharmaceutical company developing anti-infectives against multi-drug resistant pathogens, today [...]
Aleafia Health to Launch Global Cannabis Education Platform with D2L
14/11/2018
Platform to Provide Cannabis Education Courses TORONTO, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSXV: ALEF: OTCQX: ALEAF, FRA: ARAH) (“ Aleafia ”) has entered into a global agreement with D2L ( [...]
Axsome Therapeutics Announces Completion of Patient Enrollment in the ASCEND Phase 2 Trial of AXS-05 in Major Depressive Disorder
14/11/2018
NEW YORK, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, [...]
Trillium Therapeutics Reports Third Quarter 2018 Financial and Operating Results
14/11/2018
Positive clinical update on the intratumoral trial of TTI-621, a CD47 immune checkpoint inhibitor, presented at the 2018 EORTC CLTF meeting Positive clinical update on the intravenous trial of TTI-621 presented at the [...]
Evogene Reports Third Quarter 2018 Financial Results
14/11/2018
REHOVOT, Israel, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Conference call and webcast, today at 9:00 am Eastern Time Evogene Ltd. (NASDAQ, TASE: EVGN), a leading biotechnology company developing novel products for life science [...]
Athenex, Inc. Announces Third Quarter 2018 Financial Results and Provides Corporate Update
14/11/2018
Third quarter revenue increased to $18.4 million compared to $14.0 million in 3Q 2017 Positive recommendation by DSMB upon second interim analysis for Oraxol Phase III program KX2-391 Phase III pivotal studies achieved [...]
MediPharm Labs Signs The Supreme Cannabis Company for Cannabis Concentrate Program
14/11/2018
TORONTO, Nov. 14, 2018 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (the “ Company ” or “ MediPharm Labs ”) is pleased to announce that its wholly owned subsidiary MediPharm Labs Inc. (“ MediPharm ”) has [...]
Canopy Rivers to Report Second Quarter Fiscal 2019 Financial Results
14/11/2018
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRES TORONTO, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Canopy Rivers Inc. (the “ Company ”) (TSXV: RIV) will report its second quarter fiscal 2019 financial [...]
Recro Pharma Announces Publication of Phase II IV Meloxicam Abdominal Hysterectomy Data in Anesthesia & Analgesia
14/11/2018
MALVERN, Pa., Nov. 14, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care settings, today [...]
Novan Phase 2 Molluscum Contagiosum Trial Achieves Statistical Significance in Preliminary Top Line Results
14/11/2018
Higher rates of complete clearance of all molluscum lesions at Week 12 for the two highest doses, SB206 8% and 12% twice-daily, more than double the rate observed in the vehicle group Clear treatment effect observed as [...]
Opthea Completes Patient Recruitment Ahead of Schedule in Phase 2b Wet AMD Clinical Trial
14/11/2018
MELBOURNE, Australia, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT), a clinical stage biopharmaceutical company developing novel biologic therapies to treat eye diseases, today announced that recruitment [...]
Terveystalo Plc: Financial calendar and AGM in 2019
14/11/2018
Terveystalo Plc Stock Exchange Release 14 November 2018 at 09:05 a.m. EET In 2019, Terveystalo Plc will publish financial reports as follows: Financial Statements Bulletin 2018 on Thursday, February 14, 2019 Annual [...]
Customer evaluation of CADScor®System compares favorably against existing methods
14/11/2018
Interim Report, January - September 2018 Malmö, November 14, 2018 Customer evaluation of CADScor®System compares favorably against existing methods "During the quarter we proudly reported that Kristianstad Central [...]
Terveystalo Group Interim Report 1 January - 30 September 2018
14/11/2018
Terveystalo Plc. Interim report 14 November 2018 at 9:00 a.m. EET Strong earnings trend continued July-September 2018 in brief Revenue increased by 3.2 percent year-on-year to EUR 160.3 million (155.4) Adjusted* EBITDA [...]
Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – September 30, 2018
14/11/2018
Message from the CEO The third quarter was dominated by extensive preparatory work relating to the planned phase III study, called “The Connection Study”. In addition to chosing the CRO (Premier Research) we have [...]
Rule 2.9 Announcement
14/11/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 14 November 2018 [...]
Saniona publishes its interim report for the third quarter 2018
14/11/2018
PRESS RELEASE November 14, 2018 Financial highlights Jan – Sep 2018 (Jan - Sep 2017) Net revenues were SEK 52.7 M (16.1 M) EBIT was SEK -19.9 M (-40.6 M) Net profit/loss was SEK -17.7 M (-34.4) Earnings per share were [...]

Pages